Hirotaka Nagashima

Donanemab in Early Symptomatic Alzheimer Disease

John R. Sims, Jennifer A. Zimmer, Cynthia Evans et al. · JAMA · 2023 · 2.6K citations · Full text

Medicine, Neurology, Neuroscience +17

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

Paresh Dandona, Pieter Gillard, Peter Senior et al. · Diabetes Care · 2018 · 252 citations

Medicine, Pharmacology, Pharmacotherapy +15

Novel Mechanism Associated With an Inherited Cardiac Arrhythmia

Michiko Furutani, Matthew C. Trudeau, Nobuhisa Hagiwara et al. · Circulation · 1999 · 192 citations

Medicine, Cardiology, Genetics +17

Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes.

Shinichi Teno, Yuko Uto, Hirotaka Nagashima et al. · Diabetes Care · 2000 · 174 citations · Full text

Medicine, Endocrinology, Internal Medicine +12

A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall

Hirotaka Nagashima, Yoshikazu Aoka, Yasunari Sakomura et al. · Journal of Vascular Surgery · 2002 · 168 citations · Full text

Medicine, Biochemistry, Medicinal Chemistry +11